Since a major activity of antitumoral TAMs is to promote antitumor immune responses and inhibit tumor progression, we then tested the overexpression of SHISA3 in BMDM on CD8+ T cell‐mediated antitumor immunity. Here, CD8A is linked to neoplasm.